Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats

<div>The profiles of the plasma concentration of berberine versus time after oral administration of Ber-loaded SLN-chitosan nanoparticles and the pure suspension of berberine in rats. Data are expressed as the mean ± SD (<i>n</i> = 10).</div>

Canadian Respiratory Journal

fig3

Figure 3

Figure 3: Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats 

Figure 3 | Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats 